The Medical Letter on Drugs and Therapeutics
- Prescription Drug Prices in the US
- Valbenazine (Ingrezza) for Tardive Dyskinesia
- Oxymetazoline Cream (Rhofade) for Rosacea
- FDA Warns Against Use of Codeine and Tramadol in Children and Breastfeeding Women
- Another Subcutaneous Immune Globulin (Cuvitru) for Primary Immunodeficiency (online only)
- Vonvendi - Recombinant von Willebrand Factor (online only)
- Comparison Table: Some Topical Drugs for Rosacea (online only)
Prescription Drug Prices in the US
May 22, 2017 (Issue: 1521)Per capita spending on prescription drugs in the US is higher than in other industrialized nations, including Canada.
- AS Kesselheim et al. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA 2016; 316:858.
- C Leopold et al. Differences in external price referencing in Europe: a descriptive overview. Health Policy 2012; 104:50.
- A Lyles. Pharmacy benefit management companies: do they create value in the US healthcare system? Pharmacoeconomics. 2017; 35:493.
- S Morgan et al. International best practices for negotiating 'reimbursement contracts' with price rebates from pharmaceutical companies. Health Aff (Millwood) 2013; 32:771.
- A Hakim and JS Ross. Obstacles to the adoption of biosimilars for chronic diseases. JAMA 2017 May 1 (epub).
- GoodRx. Available at: www.goodrx.com. Accessed May 11, 2017.
- Blink Health. Available at: www.blinkhealth.com. Accessed May 11, 2017.
- NeedyMeds. Available at: www.needymeds.org. Accessed May 11, 2017.
- JS Ross and AS Kesselheim. Prescription-drug coupons – no such thing as a free lunch. N Engl J Med 2013; 369:1188.
- National Association of Boards of Pharmacy. The Verified Internet Pharmacy Practice Sites (VIPPS) program. Available at: www.nabp.pharmacy. Accessed May 11, 2017.
- S Morgan and J Hurley. Internet pharmacy: prices on the up-and-up. CMAJ 2004; 170:945.
- FDA. Importations of drugs. Information on importation of drugs prepared by the Division of Import Operations and Policy, FDA. Available at: www.fda.gov. Accessed May 11, 2017.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.